What are the challenges in targeting GAPs in cancer therapy?
While GAPs present promising targets for cancer therapy, there are significant challenges. One of the main issues is the complexity of GTPase signaling networks and the redundancy of GAP functions. Additionally, the development of specific inhibitors that can effectively modulate GAP activity without off-target effects is a considerable hurdle.
